1. Home
  2. NX vs AMPH Comparison

NX vs AMPH Comparison

Compare NX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$17.02

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.02

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
AMPH
Founded
1927
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
971.8M
IPO Year
2008
2005

Fundamental Metrics

Financial Performance
Metric
NX
AMPH
Price
$17.02
$18.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$28.00
$28.38
AVG Volume (30 Days)
267.3K
580.8K
Earning Date
06-04-2026
05-07-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$1,837,641,000.00
$719,887,000.00
Revenue This Year
$4.26
$6.90
Revenue Next Year
$1.77
$4.64
P/E Ratio
N/A
$127.14
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$16.65
52 Week High
$22.90
$31.26

Technical Indicators

Market Signals
Indicator
NX
AMPH
Relative Strength Index (RSI) 36.09 39.14
Support Level $16.61 $17.03
Resistance Level $20.24 $24.16
Average True Range (ATR) 0.82 0.88
MACD -0.41 -0.40
Stochastic Oscillator 25.73 17.60

Price Performance

Historical Comparison
NX
AMPH

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: